Early clinical trials in paediatric oncology in Spain: a nationwide perspective
[Introduction] Cancer is the leading cause of death between the first year of life and adolescence, and some types of diseases are still a major challenge in terms of cure. There is, therefore, a major need for new drugs. Recent findings in cancer biology open the door to the development of targeted...
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2017 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/182443 |
| Acceso en línea: | http://hdl.handle.net/10261/182443 |
| Access Level: | acceso abierto |
| Palabra clave: | Oncología y hematología pediátrica Ensayos clínicos precoces Desarrollo de nuevos fármacos Medicina personalizada Paediatric haematology and oncology Early phase clinical trials Drug development Personalised medicine |
| Sumario: | [Introduction] Cancer is the leading cause of death between the first year of life and adolescence, and some types of diseases are still a major challenge in terms of cure. There is, therefore, a major need for new drugs. Recent findings in cancer biology open the door to the development of targeted therapies against individual molecular changes, as well as immunotherapy. Promising results in adult anti-cancer drug development have not yet been translated into paediatric clinical practice. A report is presented on the activity in early paediatric oncology trials (phase I-II) in Spain. |
|---|